Code | Display | Definition |
A | ALIMENTARY TRACT AND METABOLISM | |
A01 | STOMATOLOGICAL PREPARATIONS | |
A01A | STOMATOLOGICAL PREPARATIONS | |
A01AA | Caries prophylactic agents | |
A01AA01 | sodium fluoride | |
A01AA02 | sodium monofluorophosphate | |
A01AA03 | olaflur | |
A01AA04 | stannous fluoride | |
A01AA30 | combinations | |
A01AA51 | sodium fluoride, combinations | |
A01AB | Antiinfectives and antiseptics for local oral treatment | |
A01AB02 | hydrogen peroxide | |
A01AB03 | chlorhexidine | |
A01AB04 | amphotericin B | |
A01AB05 | polynoxylin | |
A01AB06 | domiphen | |
A01AB07 | oxyquinoline | |
A01AB08 | neomycin | |
A01AB09 | miconazole | |
A01AB10 | natamycin | |
A01AB11 | various | |
A01AB12 | hexetidine | |
A01AB13 | tetracycline | |
A01AB14 | benzoxonium chloride | |
A01AB15 | tibezonium iodide | |
A01AB16 | mepartricin | |
A01AB17 | metronidazole | |
A01AB18 | clotrimazole | |
A01AB19 | sodium perborate | |
A01AB21 | chlortetracycline | |
A01AB22 | doxycycline | |
A01AB23 | minocycline | |
A01AC | Corticosteroids for local oral treatment | |
A01AC01 | triamcinolone | |
A01AC02 | dexamethasone | |
A01AC03 | hydrocortisone | |
A01AC54 | prednisolone, combinations | |
A01AD | Other agents for local oral treatment | |
A01AD01 | epinephrine | |
A01AD02 | benzydamine | |
A01AD05 | acetylsalicylic acid | |
A01AD06 | adrenalone | |
A01AD07 | amlexanox | |
A01AD08 | becaplermin | |
A01AD11 | various | |
A02 | DRUGS FOR ACID RELATED DISORDERS | |
A02A | ANTACIDS | |
A02AA | Magnesium compounds | |
A02AA01 | magnesium carbonate | |
A02AA02 | magnesium oxide | |
A02AA03 | magnesium peroxide | |
A02AA04 | magnesium hydroxide | |
A02AA05 | magnesium silicate | |
A02AA10 | combinations | |
A02AB | Aluminium compounds | |
A02AB01 | aluminium hydroxide | |
A02AB02 | algeldrate | |
A02AB03 | aluminium phosphate | |
A02AB04 | dihydroxialumini sodium carbonate | |
A02AB05 | aluminium acetoacetate | |
A02AB06 | aloglutamol | |
A02AB07 | aluminium glycinate | |
A02AB10 | combinations | |
A02AC | Calcium compounds | |
A02AC01 | calcium carbonate | |
A02AC02 | calcium silicate | |
A02AC10 | combinations | |
A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds | |
A02AD01 | ordinary salt combinations | |
A02AD02 | magaldrate | |
A02AD03 | almagate | |
A02AD04 | hydrotalcite | |
A02AD05 | almasilate | |
A02AF | Antacids with antiflatulents | |
A02AF01 | magaldrate and antiflatulents | |
A02AF02 | ordinary salt combinations and antiflatulents | |
A02AG | Antacids with antispasmodics | |
A02AH | Antacids with sodium bicarbonate | |
A02AX | Antacids, other combinations | |
A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | |
A02BA | H2-receptor antagonists | |
A02BA01 | cimetidine | |
A02BA02 | ranitidine | |
A02BA03 | famotidine | |
A02BA04 | nizatidine | |
A02BA05 | niperotidine | |
A02BA06 | roxatidine | |
A02BA07 | ranitidine bismuth citrate | |
A02BA08 | lafutidine | |
A02BA51 | cimetidine, combinations | |
A02BA53 | famotidine, combinations | |
A02BB | Prostaglandins | |
A02BB01 | misoprostol | |
A02BB02 | enprostil | |
A02BC | Proton pump inhibitors | |
A02BC01 | omeprazole | |
A02BC02 | pantoprazole | |
A02BC03 | lansoprazole | |
A02BC04 | rabeprazole | |
A02BC05 | esomeprazole | |
A02BC06 | dexlansoprazole | |
A02BC07 | dexrabeprazole | |
A02BC53 | lansoprazole, combinations | |
A02BC54 | rabeprazole, combinations | |
A02BD | Combinations for eradication of Helicobacter pylori | |
A02BD01 | omeprazole, amoxicillin and metronidazole | |
A02BD02 | lansoprazole, tetracycline and metronidazole | |
A02BD03 | lansoprazole, amoxicillin and metronidazole | |
A02BD04 | pantoprazole, amoxicillin and clarithromycin | |
A02BD05 | omeprazole, amoxicillin and clarithromycin | |
A02BD06 | esomeprazole, amoxicillin and clarithromycin | |
A02BD07 | lansoprazole, amoxicillin and clarithromycin | |
A02BD08 | bismuth subcitrate, tetracycline and metronidazole | |
A02BD09 | lansoprazole, clarithromycin and tinidazole | |
A02BD10 | lansoprazole, amoxicillin and levofloxacin | |
A02BD11 | pantoprazole, amoxicillin, clarithromycin and metronidazole | |
A02BD12 | rabeprazole, amoxicillin and clarithromycin | |
A02BD13 | rabeprazole, amoxicillin and metronidazole | |
A02BD14 | vonoprazan, amoxicillin and clarithromycin | |
A02BD15 | vonoprazan, amoxicillin and metronidazole | |
A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | |
A02BX01 | carbenoxolone | |
A02BX02 | sucralfate | |
A02BX03 | pirenzepine | |
A02BX04 | methiosulfonium chloride | |
A02BX05 | bismuth subcitrate | |
A02BX06 | proglumide | |
A02BX07 | gefarnate | |
A02BX08 | sulglicotide | |
A02BX09 | acetoxolone | |
A02BX10 | zolimidine | |
A02BX11 | troxipide | |
A02BX12 | bismuth subnitrate | |
A02BX13 | alginic acid | |
A02BX14 | rebamipide | |
A02BX51 | carbenoxolone, combinations excl. psycholeptics | |
A02BX71 | carbenoxolone, combinations with psycholeptics | |
A02BX77 | gefarnate, combinations with psycholeptics | |
A02X | OTHER DRUGS FOR ACID RELATED DISORDERS | |
A03 | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | |
A03A | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | |
A03AA | Synthetic anticholinergics, esters with tertiary amino group | |
A03AA01 | oxyphencyclimine | |
A03AA03 | camylofin | |
A03AA04 | mebeverine | |
A03AA05 | trimebutine | |
A03AA06 | rociverine | |
A03AA07 | dicycloverine | |
A03AA08 | dihexyverine | |
A03AA09 | difemerine | |
A03AA30 | piperidolate | |
A03AB | Synthetic anticholinergics, quaternary ammonium compounds | |
A03AB01 | benzilone | |
A03AB02 | glycopyrronium bromide | |
A03AB03 | oxyphenonium | |
A03AB04 | penthienate | |
A03AB05 | propantheline | |
A03AB06 | otilonium bromide | |
A03AB07 | methantheline | |
A03AB08 | tridihexethyl | |
A03AB09 | isopropamide | |
A03AB10 | hexocyclium | |
A03AB11 | poldine | |
A03AB12 | mepenzolate | |
A03AB13 | bevonium | |
A03AB14 | pipenzolate | |
A03AB15 | diphemanil | |
A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammonium iodide | |
A03AB17 | tiemonium iodide | |
A03AB18 | prifinium bromide | |
A03AB19 | timepidium bromide | |
A03AB21 | fenpiverinium | |
A03AB53 | oxyphenonium, combinations | |
A03AC | Synthetic antispasmodics, amides with tertiary amines | |
A03AC02 | dimethylaminopropionylphenothiazine | |
A03AC04 | nicofetamide | |
A03AC05 | tiropramide | |
A03AD | Papaverine and derivatives | |
A03AD01 | papaverine | |
A03AD02 | drotaverine | |
A03AD30 | moxaverine | |
A03AE | Serotonin receptor antagonists | |
A03AE01 | alosetron | |
A03AE03 | cilansetron | |
A03AX | Other drugs for functional gastrointestinal disorders | |
A03AX01 | fenpiprane | |
A03AX02 | diisopromine | |
A03AX03 | chlorbenzoxamine | |
A03AX04 | pinaverium | |
A03AX05 | fenoverine | |
A03AX06 | idanpramine | |
A03AX07 | proxazole | |
A03AX08 | alverine | |
A03AX09 | trepibutone | |
A03AX10 | isometheptene | |
A03AX11 | caroverine | |
A03AX12 | phloroglucinol | |
A03AX13 | silicones | |
A03AX14 | valethamate | |
A03AX30 | trimethyldiphenylpropylamine | |
A03AX58 | alverine, combinations | |
A03B | BELLADONNA AND DERIVATIVES, PLAIN | |
A03BA | Belladonna alkaloids, tertiary amines | |
A03BA01 | atropine | |
A03BA03 | hyoscyamine | |
A03BA04 | belladonna total alkaloids | |
A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds | |
A03BB01 | butylscopolamine | |
A03BB02 | methylatropine | |
A03BB03 | methylscopolamine | |
A03BB04 | fentonium | |
A03BB05 | cimetropium bromide | |
A03BB06 | homatropine methylbromide | |
A03C | ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS | |
A03CA | Synthetic anticholinergic agents in combination with psycholeptics | |
A03CA01 | isopropamide and psycholeptics | |
A03CA02 | clidinium and psycholeptics | |
A03CA03 | oxyphencyclimine and psycholeptics | |
A03CA04 | otilonium bromide and psycholeptics | |
A03CA05 | glycopyrronium bromide and psycholeptics | |
A03CA06 | bevonium and psycholeptics | |
A03CA07 | ambutonium and psycholeptics | |
A03CA08 | diphemanil and psycholeptics | |
A03CA09 | pipenzolate and psycholeptics | |
A03CA30 | emepronium and psycholeptics | |
A03CA34 | propantheline and psycholeptics | |
A03CB | Belladonna and derivatives in combination with psycholeptics | |
A03CB01 | methylscopolamine and psycholeptics | |
A03CB02 | belladonna total alkaloids and psycholeptics | |
A03CB03 | atropine and psycholeptics | |
A03CB04 | methylhomatropine and psycholeptics | |
A03CB31 | hyoscyamine and psycholeptics | |
A03CC | Other antispasmodics in combination with psycholeptics | |
A03D | ANTISPASMODICS IN COMBINATION WITH ANALGESICS | |
A03DA | Synthetic anticholinergic agents in combination with analgesics | |
A03DA01 | tropenzilone and analgesics | |
A03DA02 | pitofenone and analgesics | |
A03DA03 | bevonium and analgesics | |
A03DA04 | ciclonium and analgesics | |
A03DA05 | camylofin and analgesics | |
A03DA06 | trospium and analgesics | |
A03DA07 | tiemonium iodide and analgesics | |
A03DB | Belladonna and derivatives in combination with analgesics | |
A03DB04 | butylscopolamine and analgesics | |
A03DC | Other antispasmodics in combination with analgesics | |
A03E | ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS | |
A03EA | Antispasmodics, psycholeptics and analgesics in combination | |
A03ED | Antispasmodics in combination with other drugs | |
A03F | PROPULSIVES | |
A03FA | Propulsives | |
A03FA01 | metoclopramide | |
A03FA02 | cisapride | |
A03FA03 | domperidone | |
A03FA04 | bromopride | |
A03FA05 | alizapride | |
A03FA06 | clebopride | |
A03FA07 | itopride | |
A03FA08 | cinitapride | |
A03FA09 | mosapride | |
A04 | ANTIEMETICS AND ANTINAUSEANTS | |
A04A | ANTIEMETICS AND ANTINAUSEANTS | |
A04AA | Serotonin (5HT3) antagonists | |
A04AA01 | ondansetron | |
A04AA02 | granisetron | |
A04AA03 | tropisetron | |
A04AA04 | dolasetron | |
A04AA05 | palonosetron | |
A04AA55 | palonosetron, combinations | |
A04AD | Other antiemetics | |
A04AD01 | scopolamine | |
A04AD02 | cerium oxalate | |
A04AD04 | chlorobutanol | |
A04AD05 | metopimazine | |
A04AD10 | dronabinol | |
A04AD11 | nabilone | |
A04AD12 | aprepitant | |
A04AD13 | casopitant | |
A04AD14 | rolapitant | |
A04AD51 | scopolamine, combinations | |
A04AD54 | chlorobutanol, combinations | |
B | BLOOD AND BLOOD FORMING ORGANS | |
C | CARDIOVASCULAR SYSTEM | |
C10 | LIPID MODIFYING AGENTS | |
C10A | LIPID MODIFYING AGENTS, PLAIN | |
C10AA | HMG CoA reductase inhibitors | |
C10AA01 | simvastatin | |
D | DERMATOLOGICALS | |
G | GENITO URINARY SYSTEM AND SEX HORMONES | |
G02 | OTHER GYNECOLOGICALS | |
G02C | OTHER GYNECOLOGICALS | |
G02CX | Other gynecologicals | |
G02CX04 | Cimicifugae rhizoma | |
H | SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | |
J | ANTIINFECTIVES FOR SYSTEMIC USE | |
J07 | VACCINES | |
J07C | BACTERIAL AND VIRAL VACCINES, COMBINED | |
J07CA | Bacterial and viral vaccines, combined | |
J07CA02 | diphtheria-pertussis-poliomyelitis-tetanus | |
L | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | |
L02 | ENDOCRINE THERAPY | |
L02B | HORMONE ANTAGONISTS AND RELATED AGENTS | |
L02BG | Aromatase inhibitors | |
L02BG03 | anastrozole | |
M | MUSCULO-SKELETAL SYSTEM | |
N | NERVOUS SYSTEM | |
N02 | ANALGESICS | |
N02A | OPIOIDS | |
N02AA | Natural opium alkaloids | |
N02AA01 | morphine | |
N02AA02 | opium | |
N02AA03 | hydromorphone | |
N02AA04 | nicomorphine | |
N02AA05 | oxycodone | |
N02AA08 | dihydrocodeine | |
N02AA10 | papaveretum | |
N02AA51 | morphine, combinations | |
N02AA53 | hydromorphone and naloxone | |
N02AA55 | oxycodone and naloxone | |
N02AA56 | oxycodone and naltrexone | |
N02AA58 | dihydrocodeine, combinations | |
N02AA59 | codeine, combinations excl. psycholeptics | |
N02AA79 | codeine, combinations with psycholeptics | |
N03 | ANTIEPILEPTICS | |
N03A | ANTIEPILEPTICS | |
N03AA | Barbiturates and derivatives | |
N03AA01 | methylphenobarbital | |
N03AA02 | phenobarbital | |
N03AA03 | primidone | |
N03AA04 | barbexaclone | |
N03AA30 | metharbital | |
P | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | |
R | RESPIRATORY SYSTEM | |
S | SENSORY ORGANS | |
V | VARIOUS | |